Infliximab is a tumor necrosis factor TNF-α blocker and a chimeric моноклональный IgG1 антитело and it is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and severe or disabling plaque psoriasis.
Infliximab is a tumor necrosis factor TNF-α blocker and a chimeric monoclonal IgG1 antibody and it is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and severe or disabling plaque psoriasis.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.